Search

everythinglearnresearchcommunity

for

Search:↓

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

SHBG may be a useful early indicator and treatment target for PCOS.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Most dogs with alopecia had higher than normal levels of certain hormones, but hair loss might not always be linked to these hormone changes.

Chicken feather gene mutation helps understand human hair disorders.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Quercetin may help improve symptoms of polycystic ovary syndrome.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Using stem cells from hair follicles to treat female hair loss is safe and effective after six months.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Older men with low levels of a testosterone byproduct had a higher chance of developing an irregular heartbeat.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Regulating certain sex hormones may help delay facial aging.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.